Your browser doesn't support javascript.
loading
Safety of urgent surgery for the patients with proximal femur fracture treated with platelet aggregation inhibitors: a propensity-score matching analysis.
Kim, Chul-Ho; Chang, Jae Suk; Lim, Yaeji; Lim, Dongkyung; Kim, Ji Wan.
Afiliación
  • Kim CH; Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
  • Chang JS; Department of Orthopedic Surgery, National Police Hospital, Seoul, Republic of Korea.
  • Lim Y; Department of Applied Statistics, Chung-Ang University, Seoul, Republic of Korea.
  • Lim D; Department of Applied Statistics, Chung-Ang University, Seoul, Republic of Korea.
  • Kim JW; Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea. bakpaker@hanmail.net.
Article en En | MEDLINE | ID: mdl-37768385
ABSTRACT

INTRODUCTION:

To compare the various perioperative outcomes in an urgent surgery setting among patients with proximal femur fracture (PFF) who received platelet aggregation inhibitors (PAIs) and those who did not.

METHODS:

We retrospectively reviewed the data of 1,838 patients who underwent surgery for PFF between January 2011 and January 2021. We conducted 11 propensity-score matching and compared the perioperative outcomes, including operation time, postoperative complications, hospital stay, mortality, and variables related to bleeding risk (e.g., number of transfusion profiles, hemoglobin levels, and laboratory data, including coagulation battery).

RESULTS:

Of the 492 patients who were treated with PAIs, 484 were 11 matched to the untreated control group. The PAI group showed shorter operation time than the matched control group (72.3 min for PAI vs. 77.7 min for control; P = 0.041), and the control group showed more pulmonary thromboembolism (0.2% for PAI vs 1.7% for control; P = 0.046) than the PAI group. The other complications and length of hospital stay, mortality rate, transfusion profile, and the laboratory test (except preoperative international normalized ratio, INR) showed no significant difference between the groups. Subgroup analyses of the patients treated with only aspirin (aspirin 306, matched control 306), only clopidogrel (clopidogrel 100, matched control 100), and others who were treated with dual anticoagulation (dual anticoagulation 78, matched control 78) showed no significant differences in perioperative outcomes among the groups.

CONCLUSION:

The patients who were treated with PAI could undergo PFF surgery safely without delay, which led to no significant difference in operation time, postoperative complication risk, perioperative blood transfusion, and variables related to bleeding risk. Therefore, we believe that it is unnecessary to delay surgery for patients with PFF who receive PAI.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article